Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 43 - You Need To See This

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

StockNews.com · Jan 22, 2024

NHS drug shortages are partly a political failure

Letters: Britain is pushing for patent changes in India that could increase the cost of generic drugs, writes Tim Bierley; plus letters from readers on the human cost of shortages

The Guardian - UK · Jan 22, 2024

3 Pharma Stocks to Watch in 2024 for Later Gains

The pharmaceutical industry looks well-positioned for long-term growth. Hence, pharma stocks Procaps Group (PROC), Organon (OGN) and Amphastar (AMPH) might be ideal additions to your watchlists for later gains. Read on.

StockNews.com · Jan 19, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

What’s the Best 2024 Pharma Stock Buy Among These 3 Stocks?

The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals of pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Abbvie (ABBV) to determine the most promising choice for the current year….

StockNews.com · Jan 18, 2024

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Kiplinger · Jan 18, 2024

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

The Guardian - US · Jan 18, 2024

Union Cabinet approves memoranda on health products with Netherlands, Dominican Republic, Ecuador

“The Union Cabinet on January 18 approved separate memorandum with the Netherlands, Dominican Republic and Ecuador on cooperation in the field of medical products regulation,” an official statement said.

The Hindu · Jan 18, 2024

Read news from The Economist, FT, and more,
with one subscription

3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality healthcare. Therefore, it could be wise to buy fundamentally strong medical stocks GSK (GSK), National HealthCare (NHC), and MiMedx Group…

StockNews.com · Jan 17, 2024

What to know about January's annual drug price hikes

Spoiler: There are some decreases this year, too. Here's an overview of the changing prices and what to make of them.

WEKU · Jan 17, 2024

Exclusive: AAP govt procured drugs from 2 blacklisted pharma firms with many failed quality tests

Six drugs from six pharma firms have fuelled a tussle between the Centre and the Delhi government, with both sides trying to blame each other for substandard medicines making their way to the capital’s government hospitals.

Newslaundry · Jan 17, 2024

UK sets up critical imports council to protect vital supplies

Group will tackle potential restrictions to items such as medicine amid geopolitical and climate threats

The Guardian - UK · Jan 17, 2024

NHS Medicine Shortage Raises Concerns Over Patient Safety

There is a notable 100 per cent surge in medicine shortages compared to January 2022 as seen in the deteriorating health of patients across the UK.

International Business Times UK · Jan 16, 2024

3 Pharma Stocks for January 2024 Profits

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on….

StockNews.com · Jan 16, 2024

Why is there a medicine shortage in the UK? Pharmacists urge political parties to prioritise issue

34 and 11 serious shortage protocols (SSPs) were issued in 2022 and 2023 respectively

Evening Standard · Jan 15, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Jan 12, 2024

Synthetic opioids could fuel ‘second wave’ of UK drug deaths crisis, experts warn

Government urged to act as experts sound the alarm on nitazenes, with 54 deaths in past six months likely ‘tip of the iceberg’

Kiplinger · Jan 11, 2024

State Economics — Spotlight on New England: The Kiplinger Letter

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

StockNews.com · Jan 9, 2024

Are These 4 Biotech Stocks Worth Buying in 2024?

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Bayer undeterred by setback, forges ahead with US expansion

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

Get all your
news in one place.

100's of premium titles.
One news app.

Merck Hooks Harpoon Therapeutics in 0M Acquisition Spree!

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

The Hindu · Jan 6, 2024

Health Ministry notifies revised Pharma manufacturing rules under schedule M to ensure quality control

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

FDA allowing drug imports from Canada to lower prescription costs

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

The Independent UK · Jan 5, 2024

US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region

The Guardian - US · Jan 5, 2024

FDA approves program to allow Florida to import Canadian prescription drugs

State will be first to import drugs under federal program that Florida governor says could save consumers $150m in first year

FDA Approves Florida's Groundbreaking Prescription Drug Import Plan from Canada

FDA clears Florida's plan to import cheaper prescription drugs from Canada, marking a seismic shift in U.S. drug pricing and a win for consumers.

The Independent UK · Jan 5, 2024

Florida can import prescription drugs from Canada, US regulators say

Federal officials have cleared the way for Florida to begin importing cheaper prescription drugs from Canada

1 … 42 43 44 45

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.